Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8143)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 27, 2019 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Citores MJ, Lucena JL, de la Fuente S, Cuervas-Mons V. Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation. World J Hepatol 2019; 11(1): 50-64 [PMID: 30705718 DOI: 10.4254/wjh.v11.i1.50] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i1/50.htm |
| Number | Citing Articles |
| 1 |
Longqing Shi, Zhen Qu, Yue Yang, Yue Zhang, Donglin Sun, Min Tang. Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/8195512
|
| 2 |
Eric Vibert, Myron Schwartz, Kim M. Olthoff. Advances in resection and transplantation for hepatocellular carcinoma. Journal of Hepatology 2020; 72(2): 262 doi: 10.1016/j.jhep.2019.11.017
|
| 3 |
Songping Cui, Shuang Cao, Qing Chen, Qiang He, Ren Lang. Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1118053
|
| 4 |
Dincer Ozgor, Emrah Otan. HCC and Tumor Biomarkers: Does One Size Fits All?. Journal of Gastrointestinal Cancer 2020; 51(4): 1122 doi: 10.1007/s12029-020-00485-x
|
| 5 |
Chloé Paul, Camille Besch, Thierry Artzner, Baptiste Michard, Caterina Cusumano, Pietro Addeo, Philippe Bachellier, François Faitot. Additional value of interleukin-6 level to predict histopathological features of hepatocellular carcinoma before liver transplantation. Cytokine 2023; 169: 156286 doi: 10.1016/j.cyto.2023.156286
|
| 6 |
Riccardo Pravisani, Federico Mocchegiani, Miriam Isola, Dario Lorenzin, Gian Luigi Adani, Vittorio Cherchi, Maria De Martino, Andrea Risaliti, Quirino Lai, Marco Vivarelli, Umberto Baccarani. Postoperative Trends and Prognostic Values of Inflammatory and Nutritional Biomarkers after Liver Transplantation for Hepatocellular Carcinoma. Cancers 2021; 13(3): 513 doi: 10.3390/cancers13030513
|
| 7 |
Hugo Pinto Marques, Sílvia Gomes da Silva, Eleonora De Martin, Vatche G. Agopian, Paulo N. Martins. Emerging biomarkers in HCC patients: Current status. International Journal of Surgery 2020; 82: 70 doi: 10.1016/j.ijsu.2020.04.043
|
| 8 |
Badar Hasan, Yasar Colak, Rumman A. Khalid, Michael Castillo, Daniel Castaneda, Kanwarpreet Tandon, Joshua J. Shaw, Tolga Erim, Xaralambos B. Zervos, Fernando J. Castro, Kawtar Al-Khalloufi. Early Detection of Hepatocellular Carcinoma Recurrence in the Posttransplant Population: A Comparison of RETREAT and Cleveland Clinic Florida Scoring System. Transplantation Proceedings 2021; 53(1): 193 doi: 10.1016/j.transproceed.2020.09.015
|
| 9 |
Qi Zhang, Xingyuan Jiao, Osamah Ibrahim Khalaf. LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation. Computational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/9809990
|
| 10 |
Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article. Annals of Hepatology 2021; 22: 100249 doi: 10.1016/j.aohep.2020.08.067
|
| 11 |
José Sánchez Segura, Francisco Javier León Díaz, María Pérez Reyes, Daniel Cabañó Muñoz, Belinda Sánchez Pérez, Jose Antonio Pérez Daga, Custodia Montiel Casado, Julio Santoyo Santoyo. Predictive Models of Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplantation Proceedings 2020; 52(2): 546 doi: 10.1016/j.transproceed.2019.11.048
|
| 12 |
Ran Liu, Lin-Lin Zhu, Chun-Yu Yu, Ya-Ping Shuai, Ling-Ling Sun, Kai-Shun Bi, Qing Li. Quantitative evaluation of the compatibility effects of aidi injection on the treatment of hepatocellular carcinoma using targeted metabolomics: A new strategy on the mechanism study of an anticancer compound in traditional chinese medicine. World Journal of Traditional Chinese Medicine 2021; 7(1): 111 doi: 10.4103/wjtcm.wjtcm_86_20
|
| 13 |
Ajacio Bandeira de Mello Brandão, Santiago Rodriguez, Cláudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Matheus V. Fernandes, Marcos Mucenic. Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative study. Annals of Hepatology 2024; 29(2): 101184 doi: 10.1016/j.aohep.2023.101184
|
| 14 |
Faji Yang, Yuheng Zhang, Haozhen Ren, Jinglin Wang, Longcheng Shang, Yang Liu, Wei Zhu, Xiaolei Shi. Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1480-9
|
| 15 |
Haris Muhammad, Aniqa Tehreem, Peng-Sheng Ting, Merve Gurakar, Sean Young Li, Cem Simsek, Saleh A. Alqahtani, Amy K. Kim, Ruhail Kohli, Ahmet Gurakar. Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00125
|
| 16 |
Sanghwa Lee, Eunyoung Tak, Yu Jeong Cho, Jiye Kim, Jooyoung Lee, Ryunjin Lee, Kwanhee Lee, Minsung Kwon, Young-In Yoon, Sung-Gyu Lee, Jung-Man Namgoong, Jun Ki Kim. Nano-biomarker-Based Surface-Enhanced Raman Spectroscopy for Selective Diagnosis of Gallbladder and Liver Injury. BioChip Journal 2022; 16(1): 49 doi: 10.1007/s13206-022-00045-4
|
| 17 |
Yufeng Zhu, Jie He, Xingcai Luo. Prognostic Value of Computed Tomography Texture Features in Patients with Hepatocellular Carcinoma Following Stereotactic Ablative Radiotherapy. Iranian Journal of Radiology 2022; 19(1) doi: 10.5812/iranjradiol-118338
|
| 18 |
Yunhua Tang, Tielong Wang, Weiqiang Ju, Fangcong Li, Qi Zhang, Zhitao Chen, Jinlong Gong, Qiang Zhao, Dongping Wang, Maogen Chen, Zhiyong Guo, Xiaoshun He. Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.773535
|
| 19 |
Tae Yun Lee, Ho Joong Choi, Joseph Ahn, Tae Ho Hong, Young-Kyoung You. Efficacy of Tumor Markers After Liver Transplantation In Patients With Hepatocellular Carcinoma. Transplantation Proceedings 2022; 54(2): 461 doi: 10.1016/j.transproceed.2022.01.007
|
| 20 |
Sanghwa Lee, Jeongmin Oh, Kwanhee Lee, Minju Cho, Bjorn Paulson, Jun Ki Kim. Diagnosis of Ischemic Renal Failure Using Surface-Enhanced Raman Spectroscopy and a Machine Learning Algorithm. Analytical Chemistry 2022; 94(50): 17477 doi: 10.1021/acs.analchem.2c03634
|
| 21 |
Nobuhisa Akamatsu, Kiyoshi Hasegawa, Norihiro Kokudo, Masatoshi Makuuchi. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. 2022; : 501 doi: 10.1007/978-981-19-0063-1_65
|
| 22 |
Jiong‐Ze Fang, Li Xiang, Yang‐Ke Hu, Yong Yang, Hong‐Da Zhu, Cai‐De Lu. Options for the treatment of intrahepatic recurrent hepatocellular carcinoma: Salvage liver transplantation or rehepatectomy?. Clinical Transplantation 2020; 34(5) doi: 10.1111/ctr.13831
|
| 23 |
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and management. Liver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
|
| 24 |
Nourhan Badwei, Waheed A. Monsef, Iman Montasser, Mohamed Bahaa, Mahmoud El Meteini, Shimaa Y. Kamel. Role of inflammatory markers in predicting hepatocellular carcinoma recurrence after liver transplantation. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00105-8
|
| 25 |
文燕 章. Molecular Markers and Recurrence of Hepatocellular Carcinoma after Liver Transplantation. Advances in Clinical Medicine 2019; 9(03): 310 doi: 10.12677/ACM.2019.93047
|
| 26 |
Peng‐Xiang Wang, Yang Xu, Yun‐Fan Sun, Jian‐Wen Cheng, Kai‐Qian Zhou, Sui‐Yi Wu, Bo Hu, Ze‐Fan Zhang, Wei Guo, Ya Cao, Xiao‐Wu Huang, Jian Zhou, Jia Fan, Xin‐Rong Yang. Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation. Liver International 2021; 41(3): 562 doi: 10.1111/liv.14734
|